ANAVEX LIFE SCIENCES CORP. - COMMON STOCK
8.0300
14-November-24 15:45:00
15 minutes delayed
Stocks
-0.8600
-9.67%
Today's range
8.0000 - 9.2400
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK
10 Apr 2024 08:45:13 By NetDania Notify
-
NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK
09 Apr 2024 10:40:41 By NetDania Notify
-
NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK
05 Apr 2024 08:45:11 By NetDania Notify
-
NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK
03 Apr 2024 08:47:20 By NetDania Notify
-
NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK
25 Mar 2024 08:56:56 By NetDania Notify
-
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
25 Mar 2024 06:30:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK
22 Mar 2024 12:51:31 By NetDania Notify
-
18 Mar 2024 06:30:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK
26 Feb 2024 08:45:23 By NetDania Notify
-
Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference
26 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: ANAVEX LIFE SCIENCES CORP. - COMMON STOCK
23 Feb 2024 08:51:18 By NetDania Notify
-
07 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
01 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
24 Jan 2024 06:30:00 By Nasdaq GlobeNewswire
-
Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
16 Jan 2024 06:30:00 By Nasdaq GlobeNewswire
-
08 Jan 2024 06:30:00 By Nasdaq GlobeNewswire
-
Anavex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 06:30:00 By Nasdaq GlobeNewswire
-
Anavex Life Sciences Provides an Update on Rett Syndrome Program
02 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
20 Dec 2023 06:30:00 By Nasdaq GlobeNewswire